IBDEI0DM ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18313,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,18314,0)
 ;;=V13.4^^116^1006^47
 ;;^UTILITY(U,$J,358.3,18314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18314,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,18314,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,18314,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,18315,0)
 ;;=V12.72^^116^1006^48
 ;;^UTILITY(U,$J,358.3,18315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18315,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,18315,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,18315,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,18316,0)
 ;;=V12.59^^116^1006^49
 ;;^UTILITY(U,$J,358.3,18316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18316,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,18316,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,18316,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,18317,0)
 ;;=V45.81^^116^1006^50
 ;;^UTILITY(U,$J,358.3,18317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18317,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,18317,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,18317,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,18318,0)
 ;;=V15.84^^116^1006^51
 ;;^UTILITY(U,$J,358.3,18318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18318,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,18318,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,18318,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,18319,0)
 ;;=V15.85^^116^1006^57
 ;;^UTILITY(U,$J,358.3,18319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18319,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,18319,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,18319,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,18320,0)
 ;;=V10.72^^116^1006^53
 ;;^UTILITY(U,$J,358.3,18320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18320,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,18320,1,5,0)
 ;;=5^Personal H/O Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,18320,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,18321,0)
 ;;=V15.3^^116^1006^54
 ;;^UTILITY(U,$J,358.3,18321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18321,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,18321,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,18321,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,18322,0)
 ;;=V10.61^^116^1006^29
 ;;^UTILITY(U,$J,358.3,18322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18322,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,18322,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,18322,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,18323,0)
 ;;=V12.03^^116^1006^30
 ;;^UTILITY(U,$J,358.3,18323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18323,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,18323,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,18323,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,18324,0)
 ;;=V10.82^^116^1006^31
 ;;^UTILITY(U,$J,358.3,18324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18324,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,18324,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,18324,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,18325,0)
 ;;=V10.62^^116^1006^33
 ;;^UTILITY(U,$J,358.3,18325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18325,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,18325,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,18325,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,18326,0)
 ;;=V10.63^^116^1006^32
 ;;^UTILITY(U,$J,358.3,18326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18326,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,18326,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,18326,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,18327,0)
 ;;=V11.2^^116^1006^27
 ;;^UTILITY(U,$J,358.3,18327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18327,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,18327,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,18327,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,18328,0)
 ;;=V15.81^^116^1006^43
 ;;^UTILITY(U,$J,358.3,18328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18328,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,18328,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,18328,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,18329,0)
 ;;=V10.43^^116^1006^34
 ;;^UTILITY(U,$J,358.3,18329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18329,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,18329,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,18329,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,18330,0)
 ;;=V12.71^^116^1006^35
 ;;^UTILITY(U,$J,358.3,18330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18330,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,18330,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,18330,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,18331,0)
 ;;=V10.46^^116^1006^36
 ;;^UTILITY(U,$J,358.3,18331,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18331,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,18331,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,18331,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,18332,0)
 ;;=V11.0^^116^1006^37
 ;;^UTILITY(U,$J,358.3,18332,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18332,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,18332,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,18332,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,18333,0)
 ;;=V10.83^^116^1006^38
 ;;^UTILITY(U,$J,358.3,18333,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18333,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,18333,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,18333,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,18334,0)
 ;;=V15.1^^116^1006^39
 ;;^UTILITY(U,$J,358.3,18334,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18334,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,18334,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,18334,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,18335,0)
 ;;=V15.82^^116^1006^41
 ;;^UTILITY(U,$J,358.3,18335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18335,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,18335,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,18335,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,18336,0)
 ;;=V12.01^^116^1006^40
 ;;^UTILITY(U,$J,358.3,18336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18336,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,18336,1,5,0)
 ;;=5^Hx Of TB
 ;;^UTILITY(U,$J,358.3,18336,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,18337,0)
 ;;=V13.01^^116^1006^28
 ;;^UTILITY(U,$J,358.3,18337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18337,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,18337,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,18337,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,18338,0)
 ;;=V12.51^^116^1006^42
 ;;^UTILITY(U,$J,358.3,18338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18338,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,18338,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,18338,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,18339,0)
 ;;=V17.89^^116^1006^17
 ;;^UTILITY(U,$J,358.3,18339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18339,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,18339,1,5,0)
 ;;=5^Family H/O Musculosk Dis
 ;;^UTILITY(U,$J,358.3,18339,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,18340,0)
 ;;=V12.54^^116^1006^26
 ;;^UTILITY(U,$J,358.3,18340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18340,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,18340,1,5,0)
 ;;=5^HX of TIA
 ;;^UTILITY(U,$J,358.3,18340,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,18341,0)
 ;;=V12.54^^116^1006^25
 ;;^UTILITY(U,$J,358.3,18341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18341,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,18341,1,5,0)
 ;;=5^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,18341,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,18342,0)
 ;;=V15.88^^116^1006^23
 ;;^UTILITY(U,$J,358.3,18342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18342,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,18342,1,5,0)
 ;;=5^HX of Falls
 ;;^UTILITY(U,$J,358.3,18342,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,18343,0)
 ;;=V13.59^^116^1006^24
 ;;^UTILITY(U,$J,358.3,18343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18343,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,18343,1,5,0)
 ;;=5^HX of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,18343,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,18344,0)
 ;;=V12.04^^116^1006^55
 ;;^UTILITY(U,$J,358.3,18344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18344,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,18344,1,5,0)
 ;;=5^Personal H/O MRSA infection
 ;;^UTILITY(U,$J,358.3,18344,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,18345,0)
 ;;=V62.22^^116^1006^58
 ;;^UTILITY(U,$J,358.3,18345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18345,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,18345,1,5,0)
 ;;=5^Personal H/O Retrn Military Deploy
 ;;^UTILITY(U,$J,358.3,18345,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,18346,0)
 ;;=V13.51^^116^1006^56
 ;;^UTILITY(U,$J,358.3,18346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18346,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,18346,1,5,0)
 ;;=5^Personal H/O Pathological FX
 ;;^UTILITY(U,$J,358.3,18346,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,18347,0)
 ;;=V15.51^^116^1006^60
 ;;^UTILITY(U,$J,358.3,18347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18347,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,18347,1,5,0)
 ;;=5^Personal H/O Traumatic FX
 ;;^UTILITY(U,$J,358.3,18347,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,18348,0)
 ;;=V15.52^^116^1006^59
 ;;^UTILITY(U,$J,358.3,18348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18348,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,18348,1,5,0)
 ;;=5^Personal H/O Traumatic Brain Injury
 ;;^UTILITY(U,$J,358.3,18348,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,18349,0)
 ;;=V70.0^^116^1007^7
 ;;^UTILITY(U,$J,358.3,18349,1,0)
 ;;=^358.31IA^5^2
